Format

Send to

Choose Destination
Trends Genet. 2014 Oct;30(10):430-8. doi: 10.1016/j.tig.2014.07.006. Epub 2014 Aug 26.

Alternative splicing regulation of telomerase: a new paradigm?

Author information

1
Department of Cell Biology, UT Southwestern Medical Center, Dallas, TX 75390-9039, USA.
2
Department of Cell Biology, UT Southwestern Medical Center, Dallas, TX 75390-9039, USA; Center for Excellence in Genomics Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia. Electronic address: jerry.shay@utsouthwestern.edu.

Abstract

Alternative splicing affects approximately 95% of eukaryotic genes, greatly expanding the coding capacity of complex genomes. Although our understanding of alternative splicing has increased rapidly, current knowledge of splicing regulation has largely been derived from studies of highly expressed mRNAs. Telomerase is a key example of a protein that is alternatively spliced, but it is expressed at very low levels and although it is known that misregulation of telomerase splicing is a hallmark of nearly all cancers, the details of this process are unclear. Here we review work showing that hTERT expression is in part regulated by atypical alternative splicing, perhaps due to its exceptionally low expression level. We propose that these differential regulatory mechanisms may be widely applicable to other genes and may provide new opportunities for the development of cancer therapeutics.

KEYWORDS:

RNA splicing; cancer therapy; low-abundance transcript; regulation; telomere

PMID:
25172021
PMCID:
PMC4190675
DOI:
10.1016/j.tig.2014.07.006
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center